2022-09-22 | NDAQ:CYBE | Press release

NEW YORK, September 22, 2022 /PRNewswire/ —

If you hold shares in any of the companies listed above and

want to discuss our surveys or have questions about

this notice or your rights or interests, please contact:

Joshua Rubin, Esq.

Weiss’ law

305 Broadway, 7th Floor

New York, NY 10007

(212) 682-3025

(888) 593-4771

stockinfo@weisslawllp.com

Ra Medical Systems, Inc. (NYSE: RMED)

Weiss Law Investigating Possible Breaches of Fiduciary Duty and Other Violations of Law by Board of Directors Ra Medical Systems, Inc. (NYSE: RMED) as part of the Company’s proposed merger with Catheter Precision, Inc. (“Catheter Precision”). The merger is structured as a reverse stock merger whereby all of Catheter Precision’s outstanding convertible promissory notes and equity interests are to be exchanged for common stock of RMED and options of Catheter Precision assumed by RMED. If you own RMED stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/rmed

CyberOptics Corporation (NASDAQ: CYBE)

Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of CyberOptics Corporation (NASDAQ: CYBE) in connection with the proposed acquisition of CYBE by Nordson Corporation. Pursuant to the merger agreement, CYBE shareholders will receive $54.00 in cash for each common share of CYBE held. If you own CYBE stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/cybe

Lottery.com Inc. (NASDAQ:LTRY)

Weiss Law is investigating possible breaches of fiduciary duty and violations of federal securities laws by the company’s board of directors and certain officers Lottery.com Inc. (NASDAQ:LTRY) regarding: (i) the acknowledged lack of adequate internal controls and procedures over financial reporting, including the failure to report the opening of a line of credit, the failure to properly recognize income and the cash flow statement, and the inability to continue as an ongoing operation; and (ii) failure to comply with state and federal laws governing the sale of lottery tickets. If you own LTRY stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/ltry

Terminix Global Holdings, Inc. (NYSE: TMX)

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Terminix Global Holdings, Inc. (NYSE: TMX), in connection with the proposed acquisition of TMX by Rentokil Initial plc (“Rentokil Initial”). Pursuant to the merger agreement, TMX shareholders will receive approximately 643.29 million new Rentokil Initial shares (representing approximately 128.66 million American Depositary Shares (“ADS”), based on a ratio of ADS/Rentokil Initial shares of 1:5) and about $1.3 billion in liquid. If you own TMX stock and would like to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/tmx

Show original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-weiss-law-reminds-rmed-cybe-ltry-and-tmx-shareholders-about-its-ongoing-investigations-301631635.html